All news articles for December 2012

Neptune hit with shareholders' rights lawsuit

Neptune hit with shareholders' rights lawsuit

By Hank Schultz

Neptune Technologies and Bioressources has been hit with a shareholder rights lawsuit over the Nov. 8 explosion and fire that destroyed the company’s production facility and a resulting steep decline in the company’s share price.

2012: Takeovers, health claim make overs and botanical endgames

The big industry and regulation stories of 2012

2012: Takeovers, health claim make overs and botanical endgames

By Shane Starling

Business consolidation, battling stalling economies and the belated activation of the dreaded (by most) EU health claims register – these are just a few issues that have defined the 2012 EU nutra space.

Symrise inceases Probi stake; formalises R&D partnership

Symrise-Probi partnership to deliver probiotic goods in 2014-15

By Shane Starling

German fragrance and flavours house Symrise has just last night inked a deal with Swedish probiotics firm Probi to develop a stand-alone R&D project with oral probiotic supplements the most likely product out of the pipeline in 2014-2015.

Omega Protein's Atlantic menhaden catch to be cut by 20%

Omega Protein's Atlantic menhaden catch to be cut by 20%

By Hank Schultz

Omega Protein, the largest manufacturer of fish oil omega-3s based in the US, will have to live with a 20% reduction in the amount of menhaden it can harvest in the Atlantic, the company announced recently.

Dr Oz, Dateline NBC, and M&As: 2012’s BIGGEST news

Dr Oz, Dateline NBC, and M&As: 2012’s BIGGEST news

By Stephen DANIELLS

As the last grains of sand slip out of the 2012 hourglass, NutraIngredients-USA looks back on an action packed year. From the Dr Oz effect to GMPs, and from Dateline NBC to the Chicago Tribune, there have been plenty of talking points. 

Follow us

Products

View more

Webinars